340B概况 (2023年)

由于两个因素，340B市场的采购能量近年来一直处于高水准：(1)医疗保健提供者加强了成本控制，特别是在药房等成本中心，以及(2)340供应商扩大了客户的类型。

本报告提供从2020年10月到2022年10月的医药品决策议案 (共49件) 的相关调查，特定的供应商获得最多购买能源的理由，关于替代的供应商分析。还有可取得的场合，也包含来自目前客户的满意度资料。

Purchasing energy in the 340B market has been high in recent years as (1) healthcare organizations have sought to increase savings, particularly in cost centers like pharmacies, and (2) 340B vendors have expanded the types of customers they serve. This report examines 49 recent purchase decisions validated by KLAS between October 2020 and October 2022 to understand why certain vendors are seeing the most purchase energy and who is being replaced. When available, satisfaction data from current customers is also included.